{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:55:49Z","timestamp":1790286949139,"version":"4.1.0"},"reference-count":49,"publisher":"MJS Publishing, Medical Journals Sweden AB","issue":"12","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1C1C1011730"],"award-info":[{"award-number":["NRF-2022R1C1C1011730"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Acta Oncologica"],"published-print":{"date-parts":[[2023,12,2]]},"DOI":"10.1080\/0284186x.2023.2263152","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T10:24:02Z","timestamp":1696328642000},"page":"1767-1774","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of cutaneous adverse events between second-generation tyrosine kinase inhibitors and imatinib for chronic myeloid leukemia: a systematic review and meta-analysis"],"prefix":"10.2340","volume":"62","author":[{"given":"Seung-Hyeon","family":"Cha","sequence":"first","affiliation":[{"name":"College of Pharmacy, Daegu Catholic University, Gyeongbuk, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungim","family":"Kim","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Korea University, Sejong, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Kyoung","family":"Song","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Daegu Catholic University, Gyeongbuk, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01204-6"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0071"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2021.100825"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2022.100968"},{"issue":"12","key":"e_1_3_3_7_1","first-page":"6355","article-title":"Long-term BCR-ABL1 tyrosine kinase inhibitor therapy in chronic myeloid leukemia","volume":"35","author":"Pinilla-Ibarz J","year":"2015","unstructured":"Pinilla-Ibarz J, Sweet K, Emole J, et\u00a0al. Long-term BCR-ABL1 tyrosine kinase inhibitor therapy in chronic myeloid leukemia. Anticancer Res. 2015;35(12):6355\u20136364.","journal-title":"Anticancer Res"},{"key":"e_1_3_3_8_1","unstructured":"Lexi-Drugs Online [Internet]. Hudson (OH): Lexicomp Inc.; [cited 2022 Sep 23]. Available from: http:\/\/online.lexi.com."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.11.017"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2011.01431.x"},{"issue":"1","key":"e_1_3_3_11_1","first-page":"19","article-title":"Cutaneous complications of molecular targeted therapy used in oncology","volume":"9","author":"Lupu I","year":"2016","unstructured":"Lupu I, Voiculescu N, Bacalbasa N, et\u00a0al. Cutaneous complications of molecular targeted therapy used in oncology. J Med Life. 2016;9(1):19\u201325.","journal-title":"J Med Life"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S315846"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0207"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.025"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26463"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160"},{"key":"e_1_3_3_17_1","unstructured":"U.S. Department of Health and Human Services [INTERNET]. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0.; [cited 2022 Mar 21]. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_60."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15490"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2020.7911"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25233"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-105627"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14185"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03499.x"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-021-03126-6"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01862"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12069"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0265-y"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.1375"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.5932"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000501537"},{"issue":"1","key":"e_1_3_3_34_1","first-page":"42","article-title":"Tyrosine kinase inhibitors for the treatment of Chronic-Phase chronic myeloid leukemia: long-Term patient care and management","volume":"7","author":"Bauer S","year":"2016","unstructured":"Bauer S, Buchanan S, Ryan I. Tyrosine kinase inhibitors for the treatment of Chronic-Phase chronic myeloid leukemia: long-Term patient care and management. J Adv Pract Oncol. 2016;7(1):42\u201354.","journal-title":"J Adv Pract Oncol"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12052"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2019.1634089"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-01167-2"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1160117"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13081"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.12.001"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25429"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-410688"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2208-2"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02613-1"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2020.08.009"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-601674"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01111-2"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.7522"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.7162"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0957"}],"container-title":["Acta Oncologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/0284186X.2023.2263152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:05:37Z","timestamp":1756404337000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/35202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,2]]}},"alternative-id":["10.1080\/0284186X.2023.2263152"],"URL":"https:\/\/doi.org\/10.1080\/0284186x.2023.2263152","relation":{},"ISSN":["0284-186X","1651-226X"],"issn-type":[{"value":"0284-186X","type":"print"},{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ionc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ionc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}